The post SOL Price Prediction: Targets $146-150 by End of January 2026 appeared on BitcoinEthereumNews.com. Lawrence Jengar Jan 11, 2026 11:49 Solana tradesThe post SOL Price Prediction: Targets $146-150 by End of January 2026 appeared on BitcoinEthereumNews.com. Lawrence Jengar Jan 11, 2026 11:49 Solana trades

SOL Price Prediction: Targets $146-150 by End of January 2026

2026/01/11 20:09
4 min di lettura
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.


Lawrence Jengar
Jan 11, 2026 11:49

Solana trades at $136.60 with technical indicators showing neutral momentum. Analysts forecast SOL targets between $146-150 within weeks, with key resistance at $143.

SOL Price Prediction: Technical Analysis Points to $146-150 Targets

Solana (SOL) is currently trading at $136.60, showing minimal movement with a 0.07% gain in the past 24 hours. As we analyze the technical landscape and recent analyst forecasts, several price targets emerge for the popular blockchain platform.

SOL Price Prediction Summary

Short-term target (1 week): $142-146
Medium-term forecast (1 month): $138-150 range
Bullish breakout level: $143.08 (Upper Bollinger Band)
Critical support: $135.63

What Crypto Analysts Are Saying About Solana

Recent analyst predictions from early January 2026 provide insight into potential SOL price movements. Rebeca Moen noted on January 9th that “Solana trades at $138.95 with analysts forecasting $150 targets. Technical analysis reveals key resistance at $142 could unlock 8% upside potential within weeks.”

Similarly, Darius Baruo projected on January 6th that “SOL price prediction shows bullish momentum with $162 target possible within 3 weeks, though analyst forecasts range from bearish $30-40 to optimistic $184 levels.”

The CMC AI Forecast from January 8th suggests more conservative targets, stating “The maximum trading value will be around $146.76, with a possibility of dropping to a minimum of $138.11. In January 2026, the average cost will be $142.44.”

SOL Technical Analysis Breakdown

Current technical indicators paint a mixed but cautiously optimistic picture for Solana’s price action.

The RSI reading of 56.83 places SOL in neutral territory, suggesting neither oversold nor overbought conditions. This neutral positioning provides room for movement in either direction without immediate pressure from momentum extremes.

The MACD histogram at 0.0000 indicates a potential shift in momentum, with the MACD line at 1.8888 matching the signal line. This convergence often precedes significant price movements and currently suggests bullish momentum building.

Solana’s position within the Bollinger Bands shows interesting dynamics. Trading at $136.60, SOL sits well above the middle band (SMA 20) at $130.03, with a %B position of 0.75. This indicates the price is closer to the upper band ($143.08) than the lower band ($116.98), suggesting bullish pressure but approaching resistance.

Key support levels emerge at $135.63 (immediate support) and $134.67 (strong support), while resistance appears at $137.30 (immediate) and $138.01 (strong resistance).

Solana Price Targets: Bull vs Bear Case

Bullish Scenario

A break above the $143.08 upper Bollinger Band could trigger the next leg higher toward analyst targets of $146-150. The Solana forecast becomes particularly bullish if SOL can sustain above $142, which multiple analysts have identified as a key resistance level.

Technical confirmation would come from:
– RSI moving above 65
– MACD histogram turning decisively positive
– Volume increase on any breakout attempt

Bearish Scenario

Failure to hold current levels could see SOL retreat to test support at $135.63. A break below this level would target the strong support at $134.67, and potentially the SMA 20 at $130.03.

Risk factors include:
– RSI falling below 45
– Loss of the $135.63 support level
– Broader crypto market weakness

Should You Buy SOL? Entry Strategy

Based on current technical analysis, potential entry strategies include:

Conservative approach: Wait for a pullback to the $133-135 range to enter with better risk-reward ratio.

Aggressive approach: Enter on a confirmed break above $138.01 with stop-loss at $134.67.

The current average true range (ATR) of $5.44 suggests setting stop-losses with this volatility in mind. A reasonable stop-loss from current levels would be around $131-132, providing roughly 4% downside protection.

Conclusion

The SOL price prediction for the remainder of January 2026 suggests cautious optimism, with targets in the $146-150 range appearing achievable based on both technical analysis and recent analyst forecasts. However, Solana’s success in reaching these levels depends heavily on maintaining current support and breaking through the identified resistance zones.

Current positioning near the upper Bollinger Band suggests limited immediate upside without a significant catalyst, making the Solana forecast dependent on broader market conditions and potential fundamental developments.

Disclaimer: Cryptocurrency investments carry significant risk. This analysis is for informational purposes only and should not be considered financial advice. Always conduct your own research and consider your risk tolerance before investing.

Image source: Shutterstock

Source: https://blockchain.news/news/20260111-sol-price-prediction-targets-146-150-by-end-of-january-2026

Opportunità di mercato
Logo Solana
Valore Solana (SOL)
$89.8
$89.8$89.8
+0.44%
USD
Grafico dei prezzi in tempo reale di Solana (SOL)
Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.

Potrebbe anche piacerti

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Condividi
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Condividi
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Condividi
BitcoinEthereumNews2025/09/18 05:26